In Silico identification of microRNAs predicted to regulate the drug metabolizing cytochrome P450 genes

Drug Metabolism Letters

Volumn 5, Issue 2, 2011, Pages 126-131

  Ramamoorthy, Anuradha ^a   Skaar, Todd C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioinformatic analysis; Cytochrome p450s; Microrna; Polymorphisms

Indexed keywords

CYTOCHROME P450; DRUG METABOLIZING ENZYME; MESSENGER RNA; MICRORNA;

3' UNTRANSLATED REGION; ARTICLE; COMPUTER MODEL; DRUG DISPOSITION; DRUG METABOLISM; ENVIRONMENTAL FACTOR; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; COMPUTATIONAL BIOLOGY; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PHARMACEUTICAL PREPARATIONS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79954537612     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231211795305258     Document Type: Article

References (25)

1. Ingelman-Sundberg, M.; Rodriguez-Antona, C. Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2005, 360(1460), 1563-1570.
2. Ingelman-Sundberg, M.; Sim, S. C.; Gomez, A.; Rodriguez- Antona, C. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther., 2007, 116(3), 496-526.
3. Tsuchiya, Y.; Nakajima, M.; Takagi, S.; Taniya, T.; Yokoi, T. MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res., 2006, 66(18), 9090-9098.
4. Mohri, T.; Nakajima, M.; Fukami, T.; Takamiya, M.; Aoki, Y.; Yokoi, T. Human CYP2E1 is regulated by miR-378. Biochem. Pharmacol., 2010, 79(7), 1045-1052.
5. Pan, Y. Z.; Gao, W.; Yu, A. M. MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting. Drug Metab. Dispos., 2009, 37(10), 2112-2117.
6. Takagi, S.; Nakajima, M.; Mohri, T.; Yokoi, T. Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J. Biol. Chem., 2008, 283 (15), 9674-9680.
7. To, K. K.; Zhan, Z.; Litman, T.; Bates, S.E. Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol. Cell. Biol., 2008, 28(17), 5147-5161.
8. Ambros, V.; Bartel, B.; Bartel, D. P.; Burge, C. B.; Carrington, J. C.; Chen, X.; Dreyfuss, G.; Eddy, S. R.; Griffiths-Jones, S.; Marshall, M.; Matzke, M.; Ruvkun, G.; Tuschl, T. A uniform system for microRNA annotation. RNA, 2003, 9(3), 277-279.
9. Duursma, A. M.; Kedde, M.; Schrier, M.; le Sage, C.; Agami, R. miR-148 targets human DNMT3b protein coding region. RNA, 2008, 14(5), 872-877.
10. Place, R. F.; Li, L. C.; Pookot, D.; Noonan, E. J.; Dahiya, R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. USA, 2008, 105(5), 1608-1613.
11. Orom, U. A.; Nielsen, F. C.; Lund, A. H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell, 2008, 30 (4), 460-471.
12. Griffiths-Jones, S.; Grocock, R. J.; van Dongen, S.; Bateman, A.; Enright, A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res., 2006, 34 (Database issue), D140-D144.
13. Miranda, K. C.; Huynh, T.; Tay, Y.; Ang, Y. S.; Tam, W. L.; Thomson, A. M.; Lim, B.; Rigoutsos, I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell, 2006, 126(6), 1203-1217.
14. John, B.; Enright, A. J.; Aravin, A.; Tuschl, T.; Sander, C.; Marks, D. S. Human MicroRNA targets. PLoS Biol., 2004, 2(11), e363.
15. Mishra, P. J.; Humeniuk, R.; Longo-Sorbello, G. S.; Banerjee, D.; Bertino, J. R. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc. Natl. Acad. Sci. USA, 2007, 104(33), 13513-13518.
16. Lewis, B. P.; Shih, I. H.; Jones-Rhoades, M. W.; Bartel, D. P.; Burge, C. B., Prediction of mammalian microRNA targets. Cell, 2003, 115 (7), 787-798.
17. Krek, A.; Grun, D.; Poy, M. N.; Wolf, R.; Rosenberg, L.; Epstein, E. J.; MacMenamin, P.; da Piedade, I.; Gunsalus, K. C.; Stoffel, M.; Rajewsky, N. Combinatorial microRNA target predictions. Nat. Genet., 2005, 37(5), 495-500.
18. Kertesz, M.; Iovino, N.; Unnerstall, U.; Gaul, U.; Segal, E., The role of site accessibility in microRNA target recognition. Nat. Genet., 2007, 39(10), 1278-1284.
19. Clop, A.; Marcq, F.; Takeda, H.; Pirottin, D.; Tordoir, X.; Bibe, B.; Bouix, J.; Caiment, F.; Elsen, J. M.; Eychenne, F.; Larzul, C.; Laville, E.; Meish, F.; Milenkovic, D.; Tobin, J.; Charlier, C.; Georges, M. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat. Genet., 2006, 38(7), 813-818.
20. Bao, L.; Zhou, M.; Wu, L.; Lu, L.; Goldowitz, D.; Williams, R. W.; Cui, Y. PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res., 2007, 35(Database issue), D51-D54.
21. Rae, J. M.; Johnson, M. D.; Lippman, M. E.; Flockhart, D. A. Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J. Pharmacol. Exp. Ther., 2001, 299(3), 849-857.
22. Nelson, D. R.; Zeldin, D. C.; Hoffman, S. M.; Maltais, L. J.; Wain, H. M.; Nebert, D. W. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics, 2004, 14(1), 1-18.
23. Adams, B. D.; Furneaux, H.; White, B. A. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol. Endocrinol., 2007, 21(5), 1132-1147.
24. Dunning, A. M.; Dowsett, M.; Healey, C. S.; Tee, L.; Luben, R. N.; Folkerd, E.; Novik, K. L.; Kelemen, L.; Ogata, S.; Pharoah, P. D.; Easton, D. F.; Day, N. E.; Ponder, B. A. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J. Natl. Cancer Inst., 2004, 96(12), 936-945.
25. Wang, J.; Pitarque, M.; Ingelman-Sundberg, M. 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. Biochem. Biophys. Res. Commun., 2006, 340(2), 491-497.